Australia - English - Department of Health (Therapeutic Goods Administration)

atnahs pharma australia pty ltd - naproxen sodium, quantity: 550 mg - tablet, film coated - excipient ingredients: magnesium stearate; povidone; purified water; purified talc; microcrystalline cellulose; titanium dioxide; macrogol 8000; indigo carmine; hypromellose - anaprox is indicated as an analgesic in acute migraine attacks, for the treatment of gout, rheumatoid arthritis, osteoarthritis, ankylosing spondylitis and for the relief of acute and/or chronic pain states in which there is an inflammatory component.

Bangladesh - English - DGDA (Directorate General of Drug Administration)

jayson natural product ltd. (unani) - sharbat santara - liquid

Bangladesh - English - DGDA (Directorate General of Drug Administration)

nikon laboratories ltd., (unani) - sharbat santara - liquid

Bangladesh - English - DGDA (Directorate General of Drug Administration)

hamdard laboratories (waqf) bangladesh (unani) - sharbat santara - syrup

Bangladesh - English - DGDA (Directorate General of Drug Administration)

rosemark pharmaceuticals (unani) - sharbat santara - liquid

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

manarah empire sdn. bhd. - citrus aurantiifolia; citrus limon; olea europaea; zingiber officinale; curcuma longa -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

manarah empire sdn. bhd. - olea europaea; citrus limon; zingiber officinale; curcuma longa; citrus aurantiifolia -

Australia - English - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - naproxen sodium -

United States - English - NLM (National Library of Medicine)

genentech, inc. - naproxen (unii: 57y76r9atq) (naproxen - unii:57y76r9atq) - naproxen 500 mg - carefully consider the potential benefits and risks of naprosyn, ec-naprosyn, anaprox, anaprox ds or naprosyn suspension and other treatment options before deciding to use naprosyn, ec-naprosyn, anaprox, anaprox ds or naprosyn suspension. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). naproxen as naprosyn, ec-naprosyn, anaprox, anaprox ds or naprosyn suspension is indicated: - for the relief of the signs and symptoms of rheumatoid arthritis - for the relief of the signs and symptoms of osteoarthritis - for the relief of the signs and symptoms of ankylosing spondylitis - for the relief of the signs and symptoms of juvenile arthritis naproxen as naprosyn suspension is recommended for juvenile rheumatoid arthritis in order to obtain the maximum dosage flexibility based on the patient's weight. naproxen as naprosyn, anaprox, anaprox ds and naprosyn suspension is also indicated: - for relief of the signs and symptoms of tendonitis - for r

Bangladesh - English - DGDA (Directorate General of Drug Administration)

a. h. janokallay pharmaceuticals (unani) - sharbat santara - liquid